How Scientists Synergize Antidepressant Effectiveness To Leverage Improved Depression Treatment. Ep1 https://youtu.be/gU-MnyPoHAc In this inaugural release of First-Person Science, Roger Hudson speaks with Thomas Lapointe about his recently published manuscript that explores the behavioural and brain mRNA effects of combined escitalopram (an SSRI; antidepressant) and adjunct aripiprazole (5-HT1a agonist) in rats, with a specific focus on the 5-HT1a receptor. This podcast…
How Scientists Synergize Antidepressant Effectiveness To Leverage Improved Depression Treatment. Ep1 https://youtu.be/gU-MnyPoHAc In this inaugural release of First-Person Science, Roger Hudson speaks with Thomas Lapointe about his recently published manuscript that explores the behavioural and brain mRNA effects of combined escitalopram (an SSRI; antidepressant) and adjunct aripiprazole (5-HT1a agonist) in rats, with a specific focus on the 5-HT1a receptor. This podcast…
How Cannabidiol (CBD) Offsets THC-Induced Psychosis. Neural Experiments Implicating the Hippocampus Interested in cannabis-induced psychosis, and the brain mechanisms responsible for these adverse effects? In this episode, neuroscience PhDc Roger Hudson discusses his recent manuscript, “CBD Counteracts the Psychotropic Side-Effects of THC in the Ventral Hippocampus”. Check out the YouTube video featuring point-by-point visuals, figure illustrations, and summaries for those…
Interested in increasing exposure for your published research? Curious about becoming involved with the show? Email us: firstpersonsciencepod@gmail.com.
@FirstPersonScience
Science
